Loading...
Feasibility and clinical value of circulating tumor DNA testing in patients with gastric adenocarcinomas
Gastric cancer is one of the leading causes of cancer worldwide, and this trend appears to be rising. Most patients are diagnosed at an advanced stage and thus prognosis is poor. Liquid biopsy, or circulating tumor DNA (ctDNA) testing, is emerging as a promising prognostic and/or predictive biomarke...
Na minha lista:
| Udgivet i: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6534707/ https://ncbi.nlm.nih.gov/pubmed/31183188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.01.14 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|